Authors: Laske, C Oschmann, P Tofighi, J Kuhne, BS Diehl, H Bregenzer, T Kraus, J Chatzimanolis, N Bauer, R Traupe, H Kaps, M

Citation: C. Laske et al., Prognostic value of soluble tumor necrosis factor receptors 1 and 2 in multiple sclerosis patients treated with interferon beta-1b, EUR NEUROL, 46(4), 2001, pp. 210-214

Authors: Laske, C Oschmann, P Tofighi, J Kuehne, SB Diehl, H Bregenzer, T Kraus, J Bauer, R Chatzimanolis, N Kern, A Traupe, H Kaps, M

Citation: C. Laske et al., Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation withclinical and MRI activity, ACT NEUR SC, 103(2), 2001, pp. 105-113

Authors: Kraus, J Oschmann, P Engelhardt, B Stolz, E Kuehne, BS Laske, C Schaefer, C Traupe, H Kaps, M

Citation: J. Kraus et al., CD45RA(+) ICAM-3(+) lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis, ACT NEUR SC, 102(5), 2000, pp. 326-332

Authors: Laske, C Gefeller, O Pfahlberg, A Zerr, I Schroter, A Poser, S

Citation: C. Laske et al., The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: Results of a German pilot case-control study, EUR J EPID, 15(7), 1999, pp. 631-635

Authors: Kropp, S Finkenstaedt, M Laske, C Schulz-Schaeffer, W Zerr, I Kretschmar, A Poser, S

Citation: S. Kropp et al., Value of diffusion-weighted magnetic resonance image in Creutzfeldt-Jakob disease (vol 245, pg 395, 1998), J NEUROL, 246(1), 1999, pp. 66-66

Authors: Kropp, S Zerr, I Schulz-Schaeffer, WJ Riedemann, C Bodemer, M Laske, C Kretzschmar, HA Poser, S

Citation: S. Kropp et al., Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease, NEUROSCI L, 261(1-2), 1999, pp. 124-126